EP Patent

EP3012255A4 — Stabilized crystal of tipiracil hydrochloride, and crystallization method for same

Assigned to Taiho Pharmaceutical Co Ltd · Expires 2017-02-08 · 9y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: EP3012255A4
Jurisdiction: EP
Classification: —
Expires: 2017-02-08
Drug substance claim: No
Drug product claim: No
Assignee: Taiho Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.